GB778622A - Process of manufacture of an antibiotic product having specific action against the pathogenic microbes of the animal organisms, and product obtained thereby - Google Patents

Process of manufacture of an antibiotic product having specific action against the pathogenic microbes of the animal organisms, and product obtained thereby

Info

Publication number
GB778622A
GB778622A GB8374/53A GB837453A GB778622A GB 778622 A GB778622 A GB 778622A GB 8374/53 A GB8374/53 A GB 8374/53A GB 837453 A GB837453 A GB 837453A GB 778622 A GB778622 A GB 778622A
Authority
GB
United Kingdom
Prior art keywords
micro
organism
culture
antibiotic
bacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8374/53A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ind Prodotti Agricoli I P A
Original Assignee
Ind Prodotti Agricoli I P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Prodotti Agricoli I P A filed Critical Ind Prodotti Agricoli I P A
Publication of GB778622A publication Critical patent/GB778622A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

An antibiotic effective against a particular species of pathogenic micro-organism is produced by preparing a culture of said pathogenic micro-organism and subjecting the said culture to certain physical and/or chemical means which cause the micro-organism, while still alive, to produce an antibacterial substance which, when isolated, is toxic to that particular species of micro-organism. The physical means are screened ultra-violet radiations, infra-red radiations, ultra-sonic radiations, X-ray microwaves or Wood's light. The chemical means are: (a) hydrosulphites, aldehydes or peroxides which cause a variation of the redox potential of the medium and effect the bacterial respiration; and (b) sodium chloride, sodium propionate, arsenites, organo arsenious compounds, cystine and glutathione which interfere with the normal metabolism of the cells of the micro-organisms. The antibiotic is recovered from the ozonized culture by grinding the culture with sand, adding water, stirring and filtering. The aqueous extract so formed is concentrated in vacuo. Specified micro-organisms are Bacterium coli, Salmonella Typhi, B. paratyphus A and B, Pasteurella pestis, Vibrio cholera, Pseudomonas, Aeruginosa, Mycobacterium tuberculosis, Bacterium Anthracis, Pneumococcus, Staphylococcus aureus, Epidermophyton interdigitalis and Mycobacterium Leprae.ALSO:An antibiotic effective against the pathogenic microorganism from which it is derived (see Group IV(b)) is administered to animals including humans (a) orally e.g. pills or capsules, with or without the addition of absorbent inert materials (b) rectally in the form of a suppository and (c) parenterally. Pathogens referrd to are B. coli, Salmonella Typhi, B. paratyphus A and B, Pasteurella pestis, Vibrio cholera, Pseudomones aeruginosa, Mycobacterium tuberculosis, Bacterium anthracis, Pneumococcus, Staphylococcus aurens, Epidermophyton interdigitalis and Mycobacterium Leprae.
GB8374/53A 1952-06-25 1953-03-22 Process of manufacture of an antibiotic product having specific action against the pathogenic microbes of the animal organisms, and product obtained thereby Expired GB778622A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT778622X 1952-06-25

Publications (1)

Publication Number Publication Date
GB778622A true GB778622A (en) 1957-07-10

Family

ID=11316326

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8374/53A Expired GB778622A (en) 1952-06-25 1953-03-22 Process of manufacture of an antibiotic product having specific action against the pathogenic microbes of the animal organisms, and product obtained thereby

Country Status (1)

Country Link
GB (1) GB778622A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017001677A1 (en) * 2015-07-01 2017-01-05 Deinobiotics Use of microbacterium strains for the production of antibacterial agents

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017001677A1 (en) * 2015-07-01 2017-01-05 Deinobiotics Use of microbacterium strains for the production of antibacterial agents
CN108026546A (en) * 2015-07-01 2018-05-11 德诺百迪克斯公司 Microbacterium bacterial strain is used for the purposes for producing antiseptic

Similar Documents

Publication Publication Date Title
Rubbo et al. Biocidal activities of glutaraldehyde and related compounds
Yoshinaka et al. Isolation of highly radioresistant bacterium, Arthrobacter radiotolerans nov. sp.
Van der Waaij et al. Colonization resistance of the digestive tract and the spread of bacteria to the lymphatic organs in mice
Kavanagh et al. Antibiotic Substances from Basidiomycetes: IX. Drosophila Subtarata.(Batsch Ex Fr.) Quel.
Anderson Heat reactivation of ultraviolet-inactivated bacteria
JPS60172666A (en) Packaging material for sterilized food
Abraham et al. Cephalosporin N: a new type of penicillin
MacKinnon The use of inactivators in the evaluation of disinfectants
Garibaldi et al. Iron and the bacterial spoilage of shell eggs
Parry et al. The adaptation of fungi to fungicides: adaptation to copper and mercury salts
Johnson Some observations on chitin-destroying bacteria
NO932327L (en) Pseudomonas aeruginosa and its applications in methods for biotechnological production of l-rhamnose
GB778622A (en) Process of manufacture of an antibiotic product having specific action against the pathogenic microbes of the animal organisms, and product obtained thereby
Muhktar et al. Chemotactic response of equine polymorphonuclear leucocytes to Streptococcus equi
Smith Arsenic resistance in Enterobacteria: its transmission by conjugation and by phage
Spiner et al. Effect of relative humidity on formaldehyde decontamination
US3642982A (en) Utilization of living bacteria as insecticides
McConville et al. Model of intraabdominal abscess in mice
Consigli et al. Oxidation of glucose 6-phosphate and isocitrate by Coxiella burnetii
Russell et al. Effect of phenol on Bacillus subtilis spores at elevated temperatures
US2437766A (en) Method of culturing fungi
GB1085956A (en) Improvements relating to vaccines
Waksman et al. Bactericidal action of antibiotic substances
Migaki et al. Survivor curves of bacteria exposed to surface-active agents
US2496297A (en) Process of culturing bacteria